Koers A.P. Pharma, Inc. Other OTC
Aandelen
US00202J2033
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2024 * | 148 mln. 137 mln. | Omzet 2025 * | 178 mln. 164 mln. | Marktkapitalisatie | 417 mln. 385 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -14 mln. -12,93 mln. | Nettowinst (verlies) 2025 * | 1 mln. 923K | EV/omzet 2024 * | 2,82 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,35 x |
K/w-verhouding 2024 * |
-30,8
x | K/w-verhouding 2025 * |
415
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,3% |
Recentste transcriptie over A.P. Pharma, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21-02-23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16-06-23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-11-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21-02-23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20-09-21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13-01-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,59% | 44,44 mld. | |
+41,93% | 40,03 mld. | |
-10,62% | 37,68 mld. | |
+29,92% | 31,46 mld. | |
-9,23% | 27,29 mld. | |
+12,34% | 26,29 mld. | |
+41,53% | 13,8 mld. | |
+31,49% | 12,46 mld. | |
-7,40% | 11,26 mld. |
- Beurs
- Aandelen
- Koers HRTX
- Koers